Opioid ligands are a class of G protein-coupled receptors known as opioid receptors. Dynorphins, enkephalins, endorphins, endomorphins, and nociceptin are examples of endogenous opioids. There are many opioid receptors in the brain, as well as in the spinal cord and digestive system. The body has molecules or sites called opioid receptors that are triggered by opioid substances. Opioid receptors prevent impulses from traveling along excitatory pathways in the human body.The serotonin, catecholamine, and substance P pathways are some of these pathways, and they are all thought to play a role in pain perception and feelings of wellbeing. Mu, delta, and kappa receptors are additional subclassifications of opioid receptors. While each class has its own unique way of acting, they all have some fundamental things in common. The potassium pump mechanism, which is present on the plasma membrane of most cells, powers them all.
| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V69935 | D-Ala-Gly-Phe-Met-NH2 | 82948-89-8 | D-Ala-Gly-Phe-Met-NH2 is an opioid peptide and a potent opioid delta receptor agonist (activator). |
|
V69964 | D-Ala-Gly-Phe-Met-NH2 monoacetate | 100929-65-5 | D-Ala-Gly-Phe-Met-NH2 monoacetate is an opioid peptide and a potent opioid delta receptor agonist (activator). |
|
V79355 | D3R/MOR antagonist 1 | D3R/MOR antagonist 1 (Compound 114) is a D3R/MOR antagonist (Ki 46.5 nM and 691 nM, respectively). | |
|
V78834 | D3R/MOR antagonist 2 | D3R/MOR antagonist 2 (Compound 121) is a D3R/MOR antagonist (Ki 46.5 nM and 691 nM, respectively). | |
|
V69957 | Dalargin | 81733-79-1 | Dalargin is a potent δ-opioid receptor agonist. |
|
V77107 | DALDA acetate | DALDA acetate is a potent and selective μ-opioid receptor agonist/activator with a Ki of 1.69 nM. | |
|
V79008 | DALDA TFA | DALDA TFA is a potent and selective μ-opioid receptor agonist/activator with a Ki of 1.69 nM. | |
|
V29335 | DAMGO | 78123-71-4 | DAMGO is a selective μ-opioid receptor (μ-OPR) agonist with Kd of 3.46 nM. |
|
V28668 | DAMGO TFA | 950492-85-0 | DAMGO TFA is a selective μ-opioid receptor (μ-OPR) agonist with Kd of 3.46 nM. |
|
V77093 | Deltorphin 2 TFA ([D-Ala2]-Deltorphin II TFA) | Deltorphin 2 TFA is a selective delta opioid receptor peptide agonist. | |
|
V69978 | Dermorphin Analog | 115814-08-9 | Dermorphin Analog is an analogue of Dermorphin. |
|
V19863 | Difelikefalin | 1024828-77-0 | Difelikefalin (MR-13A9; CR-845; MR-13A-9; trade name Korsuva) is a novel, peripherally specific, and potent kappa opioid receptor agonist approved in 2021 asan analgesic opiod peptide for the treatment of moderate-to-severe itching. |
|
V69918 | DIPPA hydrochloride | 155512-52-0 | DIPPA ( HCl) is an irreversible, long-acting, selective and high-affinity kappa-opioid receptor antagonist. |
|
V69882 | DPDPE | 88373-73-3 | DPDPE is an opioid peptide and a selective opioid receptor (DOR) agonist with anticonvulsant (antiepileptic/antiseizure) properties. |
|
V69885 | DPDPE TFA | 172888-59-4 | DPDPE TFA is an opioid peptide and a selective opioid receptor (DOR) agonist with anticonvulsant (antiepileptic/antiseizure) properties. |
|
V80368 | DS34942424 | DS34942424 is an orally bioactive analgesic without mu-opioid receptor agonist (activator) activity. | |
|
V77053 | Dynorphin A (1-10) (TFA) | Dynorphin A (1-10) (TFA) is an endogenous opioid neuropeptide that binds to the κ-opioid receptor. | |
|
V77052 | Dynorphin B (1-13) (TFA) (dynorphin B (1-13) trifluoroacetate) | Dynorphin B (1-13) TFA is a κ-opioid receptor agonist. | |
|
V69893 | Endomorphin 1 acetate | 1276123-71-7 | Endomorphin 1 acetate, a selective, high-affinity μ-opioid receptor agonist (Ki: 1.11 nM), has high affinity for the kappa3 binding site with Kis between 20 and 30 nM. |
|
V69967 | EST73502 | 1838622-25-5 | EST73502 is a selective, orally bioactive, BBB (blood-brain barrier) permeable (penetrable) μ-opioid receptor (μ-opioid receptor/MOR) agonist and σ1 receptor (σ1R) antagonist, acting on MOR and σ1R The Kis are 64 nM and 118 nM respectively. |
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
